Holen Sie sich die Stockscreener-App
0.0363
7.26%
0.0588
Schlusskurs vom Vortag:
$0.0951
Offen:
$0.034
24-Stunden-Volumen:
206.73K
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.71M
KGV:
-0.000545
EPS:
-66.7333
Netto-Cashflow:
$-13.81M
1W Leistung:
+7.26%
1M Leistung:
-98.11%
6M Leistung:
-99.97%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.0332
$0.0378
1-Wochen-Bereich:
$0.0332
$0.0378
52-Wochen-Spanne:
$0.0332
$0.0378
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Firmenname
Cero Therapeutics Holdings Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare CERO vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERO
Cero Therapeutics Holdings Inc
|
0.0348 | 0 | 0 | -14.71M | -13.81M | -66.73 |
VRTX
Vertex Pharmaceuticals Inc
|
458.29 | 116.36B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
743.79 | 77.96B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
685.02 | 42.36B | 4.16B | 1.29B | 734.26M | 19.59 |
ALNY
Alnylam Pharmaceuticals Inc
|
315.78 | 41.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
284.00 | 31.38B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Hochstufung | D. Boral Capital | Hold → Buy |
Cero Therapeutics Holdings Inc Aktie (CERO) Neueste Nachrichten
Insider Sell: How does CERo Therapeutics Holdings Inc score in quality rankingsWeekly Earnings Recap & Weekly Top Stock Performers List - baoquankhu1.vn
Cero Therapeutics registers up to 12.5M shares for potential sale under equity agreement with Keystone - MSN
US Market Wrap: Can CERo Therapeutics Holdings Inc Equity Warrant outperform in the next rallyMarket Weekly Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Gains Report: Will CERo Therapeutics Holdings Inc Equity Warrant outperform small cap indexes2026 Snapshot & Capital Efficient Trade Techniques - baoquankhu1.vn
CERo Therapeutics Gets Fast Track Designation For Experimental Cancer Drug, But Stock Tumbles – Here’s What Happened - MSN
Cero Therapeutics (NASDAQ: CERO) holder Isaiah Tibbs reports 8.67% stake - Stock Titan
CERO Therapeutics Holdings, Inc. Announces $750,000 Convertible Note Issuance and SEC Filing – March 2026 - Minichart
CERo Therapeutics Provides Shareholder Update - GlobeNewswire
CERo Therapeutics Enters Convertible Note Financing Agreement - TipRanks
CERo Therapeutics Raises $750,000 via Convertible Note With Keystone, Up to $1 Million Available - TradingView
Trend Report: Can CERo Therapeutics Holdings Inc deliver alphaTrade Performance Summary & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
729.6M shares registered; CERO (OTCQB: CERO) files prospectus supplement - Stock Titan
CERO Therapeutics (CERO) secures up to $1M through 10% convertible note - Stock Titan
US Market Recap: Will CERo Therapeutics Holdings Inc. Equity Warrant stock split attract more investorsWeekly Market Summary & Daily Entry Point Trade Alerts - Naître et grandir
Patterns Watch: Will CERo Therapeutics Holdings Inc Equity Warrant announce a stock split2025 Market WrapUp & AI Powered Market Trend Analysis - baoquankhu1.vn
Resistance Check: Can CERo Therapeutics Holdings Inc outperform in the next rallyWeekly Profit Recap & Expert Approved Momentum Ideas - baoquankhu1.vn
CERO SEC FilingsCERo Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors - GlobeNewswire
Cero Therapeutics Holdings Appoints New Board Member - TradingView
CERo Therapeutics Presents Positive Phase 1 Data for Leukemia Treatment - National Today
CERo Therapeutics Securities Delisted Following Nasdaq Appeal Denial - TipRanks
CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML - Yahoo Finance
CERo Therapeutics shareholders approve key capital structure changes - The Globe and Mail
Cero Therapeutics shareholders approve equity plan amendment and reverse stock split - Investing.com
Cero Therapeutics enters new stock purchase agreement for up to $14.6 million - Investing.com
CERO Downgraded to Hold by D. Boral Capital | CERO Stock News - GuruFocus
CERo Therapeutics Holdings (CERO) Price Target Increased by 33.33% to 30.60 - Nasdaq
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO - AlphaStreet
Is CERo Therapeutics Holdings Inc. still worth holding after the dipMarket Activity Recap & Daily Stock Trend Watchlist - newser.com
Is it too late to sell CERo Therapeutics Holdings Inc.2025 Support & Resistance & Weekly Momentum Stock Picks - newser.com
Published on: 2025-11-10 05:34:11 - newser.com
Can CERo Therapeutics Holdings Inc. hit a new high this monthQuarterly Trade Report & Growth Focused Entry Reports - newser.com
Short interest data insights for CERo Therapeutics Holdings Inc. Equity WarrantBear Alert & Safe Entry Point Identification - newser.com
What recovery options are there for CERo Therapeutics Holdings Inc.Options Play & Community Driven Trade Alerts - newser.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock vulnerable to regulatory risksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com
Using flow based indicators on CERo Therapeutics Holdings Inc.Market Performance Recap & Real-Time Stock Price Movement Reports - newser.com
Evaluating CERo Therapeutics Holdings Inc. with trendline analysisForecast Cut & AI Forecast Swing Trade Picks - newser.com
Can CERo Therapeutics Holdings Inc. stock deliver consistent earnings growth2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - newser.com
Is CERo Therapeutics Holdings Inc. Equity Warrant stock supported by strong fundamentals2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
Automated trading signals detected on CERo Therapeutics Holdings Inc.Portfolio Risk Report & Reliable Price Action Trade Plans - newser.com
Why CERo Therapeutics Holdings Inc. Equity Warrant stock attracts global investorsM&A Rumor & Pattern Based Trade Signal System - newser.com
Real time breakdown of CERo Therapeutics Holdings Inc. Equity Warrant stock performance - newser.com
Why CERo Therapeutics Holdings Inc. stock is considered a top pickJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
How institutional ownership impacts CERo Therapeutics Holdings Inc. Equity Warrant stockMarket Volume Report & Smart Money Movement Alerts - newser.com
Published on: 2025-11-09 13:31:30 - newser.com
Using fundamentals and technicals on CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Selloffs & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-09 08:41:28 - newser.com
Will CERo Therapeutics Holdings Inc. stock recover faster than marketOptions Play & Real-Time Volume Trigger Notifications - newser.com
CERo Therapeutics Holdings Inc. Equity Warrant stock trendline breakdownJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
Using RSI to spot recovery in CERo Therapeutics Holdings Inc. Equity Warrant2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Published on: 2025-11-08 02:29:16 - newser.com
Finanzdaten der Cero Therapeutics Holdings Inc-Aktie (CERO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.07%
Kapitalisierung:
|
Volumen (24h):